Purchase Order AG63PXP140077

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3.7 million definitive contract to Arisan Therapeutics Inc. on September 22, 2023, to conduct non-clinical Good Laboratory Practice (GLP) in vivo genotoxicity and reproductive toxicology studies, as well as GLP development and reproductive and developmental toxicology (DART) studies. The contract, which runs through December 31, 2026, carries a cost-plus-fixed-fee pricing structure and does not include a set-aside...

Pharmacology Discovery Services Taiwan, LTD. was awarded a firm fixed price delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. The $1,628,062 delivery order is for the company to provide therapeutic testing in murine models of bacterial thigh, lung and peritonitis infections, as described in Task A42 of the original solicitation. Performance will take...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $913,177 delivery order against its CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract to IIT Research Institute. IIT Research Institute, operating as the research and programs division of the Illinois Institute of Technology, will conduct three-month subcutaneous toxicity studies in dogs and mice to support the Center's drug development programs. Performance will...

The Office of the Assistant Secretary for Preparedness and Response awarded a $124.5 million firm fixed-price definitive contract to Elusys Therapeutics Inc. on May 1, 2024, for the supply and delivery of ANTHIM (obiltoxaximab), a monoclonal antitoxin therapeutic. The contract, which extends through December 31, 2028, is being performed at the contractor's facility in Parsippany, New Jersey. This award reflects the federal government's commitment to maintaining strategic medical...

Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,187,770 firm fixed price delivery order against the National Institute of Allergy and Infectious Diseases Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. The delivery order is for therapeutic testing in murine models of bacterial thigh, lung, and peritonitis infections to support the National Institute of Allergy and Infectious Diseases' pre-clinical research mission. Work will...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $268,799.00 delivery order contract to Sri International for non-clinical safety assessment of ORC-13661 to support aminoglycoside induced hearing loss indication. Sri International will perform the work as the prime contractor in West Menlo Park, California from September 14, 2022 through November 13, 2023. Bioivt, LLC will serve as a subcontractor providing a...

Inotiv Inc., doing business as BASi Research Products Division, has been awarded a $12,000 firm fixed price purchase order by the Environmental Protection Agency Office of Research and Development to provide non-GLP Ames assay services. The place of performance will be in West Lafayette, Indiana and the period of performance is expected to conclude on February 18, 2025. As a manufacturer of goods and provider of drug discovery and development services to the global pharmaceutical industry,...

This firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Ajinomoto Althea, Inc. is for stability testing of Hantaan and Puumala deoxyribonucleic acid (DNA) plasmids, in support of research conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The contract has a ceiling value of $26,700.00 and a period of performance through September 23, 2024. The contract was awarded on a sole-source basis, as Ajinomoto Althea is currently...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, has awarded a $96,829.63 firm-fixed-price purchase order to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies. The contract is for a Transcriptomics study - RNA-seq in Liver Spheroids Phase One, with the purpose of evaluating the safety and liver toxicity of candidate antisense oligonucleotides using a 3D liver microtissue...

This is a task order awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases to Battelle Memorial Institute, doing business as Battelle, a nonprofit research and development organization, to design, conduct, and assess the immunogenicity and efficacy of a plague vaccine candidate formulated with IL-2 alum-cytuvax or other novel adjuvant in mice. The task order is part of the Evaluation and Testing...